Bessemer Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17K | Sell |
517
-41
| -7% | -$1.35K | ﹤0.01% | 1613 |
|
|
2025
Q1 | $23K | Buy |
558
+7
| +1% | +$289 | ﹤0.01% | 1493 |
|
|
2024
Q4 | $26K | Sell |
551
-1,381
| -71% | -$65.2K | ﹤0.01% | 1435 |
|
|
2024
Q3 | $102K | Buy |
1,932
+716
| +59% | +$37.8K | ﹤0.01% | 1280 |
|
|
2024
Q2 | $66K | Sell |
1,216
-44
| -3% | -$2.39K | ﹤0.01% | 1233 |
|
|
2024
Q1 | $88K | Buy |
1,260
+1,255
| +25,100% | +$87.7K | ﹤0.01% | 1198 |
|
|
2023
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 2172 |
|
|
2023
Q3 | $0 | Sell |
5
-73
| -94% | – | ﹤0.01% | 2195 |
|
|
2023
Q2 | $3K | Buy |
+78
| New | +$3K | ﹤0.01% | 1933 |
|
|
2020
Q2 | – | Sell |
-2,900
| Closed | -$34K | – | 1711 |
|
|
2020
Q1 | $34K | Buy |
+2,900
| New | +$34K | ﹤0.01% | 1275 |
|
|
2016
Q1 | – | Sell |
-207
| Closed | -$2K | – | 1509 |
|
|
2015
Q4 | $2K | Buy |
+207
| New | +$2K | ﹤0.01% | 1497 |
|